As for Ivacaftor, a CFTR potentiator, which has become a cornerstone drug for the treatment of cystic fibrosis32, 33, the development of a BEST1 potentiator can be a paradigm shift for the treatment of bestrophinopathy and even provide a complete cure. This evidence concerns the gene CFTR and autosomal recessive bestrophinopathy.